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The peptide hormones uroguanylin and guanylin have been traditionally thought to be
mediators of ﬂuid–ion homeostasis in the vertebrate intestine. They serve as ligands for
receptor guanylyl cyclase C (GC-C), and both receptor and ligands are expressed predom-
inantly in the intestine. Ligand binding to GC-C results in increased cyclic GMP production
in the cell which governs downstream signaling. In the last decade, a signiﬁcant amount
of research has unraveled novel functions for this class of peptide hormones, in addition
to their action as intestinal secretagogues. An additional receptor for uroguanylin, receptor
guanylyl cyclase D, has also been identiﬁed. Thus, unconventional roles of these peptides
in regulating renal ﬁltration, olfaction, reproduction, and cell proliferation have begun to be
elucidated in detail. These varied effects suggest that these peptide hormones act in an
autocrine, paracrine as well as endocrine manner to regulate diverse cellular processes.
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INTRODUCTION
Nearly two decades ago, in a search for molecules that regulate
cyclic GMP (cGMP) levels in the intestine, guanylin was identi-
ﬁed as a low molecular weight, acid stable peptide present in rat
jejunal extracts (Currie et al., 1992). A year later, uroguanylin was
puriﬁed from opossum urine and was seen to exhibit a ten-fold
higher bio-activity as compared to guanylin (Hamra et al., 1993).
Subsequently, guanylin and uroguanylin emerged as key players in
intestinal ﬂuid homeostasis, a phenomenon fundamental to the
maintenance of gut physiology. Both these regulatory peptides are
produced in the enteroendocrine cells of the intestinal mucosa
as precursor proteins and are processed to their mature forms
by converting enzymes. The biologically active forms of guanylin
and uroguanylin have striking similarities in their structure, and
contain four conserved cysteines which form disulﬁde linkages
essential for their activity (Forte, 1999).
Guanylyl cyclase C (GC-C) is the receptor that is activated
by these peptides. Owing to its apical localization in enterocytes,
the extracellular domain of GC-C can bind uroguanylin/guanylin
released into the gut lumen, initiating production of the intracel-
lular second messenger, cGMP (Schulz et al., 1990). Cyclic GMP
activates the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) that serves as a membrane channel, modulating chlo-
ride efﬂux from the enterocytes lining the intestinal tract. This
stimulation of electrogenic chloride secretion, concomitant with
an inhibition of sodium absorption, leads to a net ﬂuid secre-
tion into the intestinal lumen. Thus, the endogenous peptides,
guanylin, and uroguanylin are involved in the regulation of salt
and water transport across the intestinal epithelia. These peptides
also regulate CFTR-mediated bicarbonate secretion and inhibit
H+ extrusion by the Na+/H+ exchanger in the small bowel. This
helps in the regulation of intestinal pH, thus stimulating the diges-
tion and absorption of food components (Basu et al., 2010).
In addition to maintenance of intestinal ﬂuid balance, guanylin
and uroguanylin target the renal tissue, eliciting natriuresis, kali-
uresis, and diuresis, along with increasing urinary cGMP levels
(Sindic and Schlatter, 2006). Uroguanylinmay also inﬂuence long-
term renal function, since down-regulation of the mRNAs of the
Na+/K− ATPase γ-subunit and the chloride channel, ClC-K2, is
also observed on uroguanylin administration (Carrithers et al.,
2004).
The heat-stable enterotoxin (ST) is a structural and functional
homolog of uroguanylin/guanylin. Pathogenic strains of E. coli,
and other bacteria that produce ST peptides, cause watery diar-
rhea as a result of the high levels of ﬂuid–ion secretion elicited
by ST binding to GC-C present on intestinal epithelial cells (Field
et al., 1978). ST is being considered as a vaccine target to com-
bat enterotoxigenic E. coli, of which some strains are endemic in
developing nations. Compared to ST, the endogenous peptides are
less potent in stimulating ﬂuid–ion secretion, since the afﬁnity
of guanylin and uroguanylin for GC-C is 100-fold and 10-fold
lower than ST respectively. ST peptides thus represent a form of
molecular mimicry wherein enterotoxigenic E. coli exploit normal
intestinal physiology for their dissemination.
Recent reports have identiﬁed guanylyl cyclase D (GC-D) as
an additional receptor for guanylin and uroguanylin. This less
characterized peptide receptor has a domain organization simi-
lar to that of GC-C, consisting of an extracellular ligand binding
domain, a single transmembrane spanning domain, followed by
a kinase homology domain linked to a guanylyl cyclase domain.
However unlike GC-C, which is expressed in the intestinal epithe-
lia, GC-D is exclusively expressed in a few neurons of the olfactory
epithelia. These cells respond to uroguanylin/guanylin by generat-
ing action potentials, probably by elevating intracellular levels of
cGMP (Zufall and Munger, 2010). Therefore, in addition to a role
for uroguanylin and guanylin as hormonal modulators of ﬂuid
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and electrolyte secretion, there may be other physiological func-
tions for the guanylin family of cGMP-regulating peptides, some
of which are discussed below.
RENAL FUNCTIONS
Apart from maintaining ﬂuid balance in the vertebrate intestine,
uroguanylin is also involved in the regulation of kidney function
and maintenance of sodium ion balance in the body. Both effects
prevent the development of hypernatremia in response to a high
oral salt load. Intravenous applicationof uroguanylin inmice stim-
ulated Na+, K+, and water excretion in the urine, suggesting that
uroguanylin, which is also expressed in the kidney, could serve
in an endocrine axis that connects the gastrointestinal tract with
the kidney for maintenance of ion balance. Thus, uroguanylin
has both local intestinal (paracrine) and endocrine functions,
forming a potential enteric–renal link to coordinate salt ingestion
with natriuresis (Forte, 2003). In support of this evidence, it was
observed that mice lacking the uroguanylin gene have increased
blood pressure and an impaired capacity to excrete Na+ in the
urine when salt loads are administered orally. However, intra-
venous administration of NaCl to uroguanylin knock-out mice
elicits natriuresis equivalent to that of wild-type animals (Lorenz
et al., 2003). Increased dietary intake of NaCl results in increased
uroguanylin expression in the intestine and kidney, implicating
both endocrine and paracrine/autocrine actions of uroguanylin
in regulation of tubular signaling mechanisms that govern renal
sodium transport (Carrithers et al., 2000).
A recent report has suggested that circulating plasma
prouroguanylin, the precursor of uroguanylin, may mediate
entero-renal signaling. Prouroguanylin is released by the enteroen-
docrine cells of the intestine in response to a salty meal and
is converted to uroguanylin in the kidney, thereby eliciting
“postprandial-natriuresis” (Moss et al., 2008; Qian et al., 2008).
This is in line with a report that a high salt diet primes the kidney
for an enhanced response to uroguanylin (Fonteles et al., 2009).
GC-C knock-out mice have normal blood pressure and renal
sodium excretion, but do not exhibit intestinal secretion in
response to ST peptides and uroguanylin/guanylin. Moreover,
when uroguanylin, guanylin, or ST peptides are administered
intravenously to GC-C knock-out mice, they elicit saluretic and
diuretic responses, quantitatively equal to that of wild-type mice
(Carrithers et al., 2004). Based on the independent phenotypes
of uroguanylin and GC-C knock-out mice, it can be suggested
that regulation of renal sodium transport is not mediated by
GC-C, but through a receptor for uroguanylin whose iden-
tity is as yet unknown, and may be coupled to a G-protein
(Sindice et al., 2002).
OLFACTORY FUNCTIONS
The neurons of main olfactory epithelia (MOE) are responsible
for sensing a myriad of odors. Canonical olfactory sensory neu-
rons act through odorant receptors and generation of cyclic AMP
(cAMP), which binds cyclic nucleotide gated (CNG) channels
leading to neuronal membrane depolarization. However, recent
research has shown that the cAMP-mediated excitatory pathway is
not the lone signaling pathway operating in theMOE. A sub-set of
these neurons which express GC-D are suspected to transduce the
signal of olfaction in a cAMP-independent manner, as opposed
to that seen in the rest of the olfactory epithelia (Fulle et al.,
1995). These cells are devoid of the cAMP signaling machinery
involving the odorant receptors, namely, Gαolf , type III adenylyl
cyclase, the cAMP-dependent phosphodiesterase (PDE4A) and the
cAMP-responsive CNG channel subunits, CNGA2 and CNGB1b.
On the other hand, these cells express a cGMP-speciﬁc CNG chan-
nel subunit CNGA3, and a cGMP-dependent phosphodiesterase
(PDE2) in addition to GC-D, highlighting the role of cGMP in
the physiology of these neurons (Meyer et al., 2000). The axons of
these GC-D neurons impinge on the “necklace glomeruli” which
reside between the main and the accessory olfactory bulb of mice
(Leinders-Zufall et al., 2007).
Through extensive gene-targeting studies in mice, Leinders-
Zufall et al. (2007) demonstrated that these neurons respond to
uroguanylin and guanylin in a cGMP-dependentmanner to induce
formation of action potentials in the MOE. Response to these uri-
nary peptides is speciﬁc to the GC-D neurons, and the presence
of GC-D has been shown to be crucial for maintenance of normal
afferent activity, as well as basal activity, of the necklace glomeruli.
GC-D knock-out mice develop the necklace glomeruli but do not
respond to the peptide hormones, and have low afferent activity
in these neurons (Leinders-Zufall et al., 2007). The GC-D neu-
rons express uroguanylin, which can act in an autocrine/paracrine
manner, but this stimulus is insufﬁcient to maintain normal affer-
ent activity in these cells which requires stimuli from the external
environment. Therefore, uroguanylin may also act as a social sig-
nal and communicate information about food. Uroguanylin levels
in the urine rise postprandially, and this may translate to spe-
ciﬁc chemosensory cues about availability or quantity of food
present in the environment (Munger et al., 2010). Recent evi-
dence shows that GC-D containing neurons can also detect and
respond to CO2 and bicarbonate which are volatile signals (Hu
et al., 2007; Sun et al., 2009). Thus, a sub-population of the MOE
responds to urinary uroguanylin and guanylin and forms a unique
cGMP-dependent chemodetection system (Figure 1).
CELL CYTOSTATIC FUNCTIONS
The intestinal epitheliumundergoeswaves of proliferation,migra-
tion, differentiation, and apoptosis driven by multipotent stem
cells. Cyclic GMP has emerged as an important regulator of this
process, although themolecular mechanismsmediating this activ-
ity are still not clear. The cGMP signal transduction pathway acti-
vated by guanylin and uroguanylin appears to help in regulating
the turnover of epithelial cells, and maintenance of homeosta-
sis of the intestinal mucosa. The expression of uroguanylin and
guanylin is markedly reduced in colon carcinoma, in stark con-
trast to GC-C, whose expression remains comparable to that seen
in normal colonic mucosa (Shailubhai et al., 2000). This has led to
the emergence of GC-Cas amarker formetastatic colon carcinoma
(Carrithers et al., 1996).
In a seminal study, Pitari et al. (2001) demonstrated that the
endogenous agonists of GC-C (uroguanylin/guanylin) play a role
in regulating the balance between epithelial proliferation and
differentiation in the normal intestine, and regulate cell cycle pro-
gression. This effect was dependent upon production of cGMP
via GC-C and release of intracellular Ca2+ (Pitari et al., 2001).
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FIGURE 1 | Non-canonical signaling by the guanylin and uroguanylin
family of peptide hormones. Binding of guanylin and uroguanylin to GC-C
in the intestinal epithelial cell results in an increase in cGMP levels.
Intracellular cGMP levels are reduced by the action of PDE5, which cleaves
cGMP to form 5′-GMP. Cyclic GMP can act directly on CNG channels to
increase cellular Ca2+ levels, resulting in colon cell cytostasis. This process
is attenuated by the action of cis-l-diltiazem (L-DLT), a CNG channel inhibitor.
The tyrosine kinase c-src which is frequently found to be activated in
colorectal carcinomas, phosphorylates and inhibits GC-C activity, thereby
reducing the anti-tumorigenic effects induced by guanylin/uroguanylin/ST
peptides. In olfactory epithelia, uroguanylin/guanylin is recognized by GC-D
expressed in a sub-set of neurons and evoke action potentials. These
neurons also ﬁre in response to CO2/HCO
−
3 . Hydrolysis of cGMP in these
cells is thought to be mediated by PDE2. The renal effects of uroguanylin
have been detailed in an earlier review, and are not shown in this ﬁgure
(Sindic and Schlatter, 2006).
This suggests that the anti-proliferative action of GC-C agonists
operate via regulation of Ca2+ inﬂux through CNG channels,
with Ca2+ serving as the third messenger in the signaling cas-
cade, linking GC-C at the cell surface to regulation of prolifer-
ation in the nucleus. Guanylin knock-out mice show increased
crypt depth and a higher number of proliferating cells, reiterating
the role of this molecule in regulating intestinal crypt biology
(Currie et al., 1992).
As with all biological phenomena, cell cycle regulation medi-
ated by GC-C is under strict regulation. One mechanism that
has been described recently is via the c-src kinase, which phos-
phorylates and thereby attenuates ligand-mediated activation of
GC-C. Colon carcinoma cells usually have enhanced c-src activ-
ity and therefore can effectively bypass the cytostatic effects of
uroguanylin (Basu et al., 2009). Prolonged GC-C stimulation
activates a cGMP-regulated, cGMP-speciﬁc phosphodiesterase 5
(PDE5),which lowers intracellular cGMP levels, and in turn affects
Ca2+ inﬂux throughCNGchannels (Pitari et al., 2005). Thus, these
negative feedback mechanisms in cGMP-signaling help shape the
duration of agonist-induced cytostasis.
Thus, GC-C and its endogenous ligands guanylin/uroguanylin,
comprise an integrated paracrine mechanism regulating crypt–
villus homeostasis by maintaining the balance between epithelial
cell proliferation and differentiation. Uroguanylin and guanylin
have also been found to be expressed in pancreatic cells and
exert a similar cytostatic effect on pancreatic cancer cells, prov-
ing that the uroguanylin/GC-C/cGMP axis may be a generalized
anti-proliferative mechanism utilized by multiple organ systems
(Kloeters et al., 2008).
Colon cancer is one of the leading causes of cancer-associated
mortality in developed countries, but its incidence is relatively low
inunderdeveloped anddeveloping countries.A common epidemi-
ological characteristic of these colon cancer-spared regions is the
prevalence of enterotoxigenic E. coli. Periodic infections with ST
producing bacteria in the intestine may elicit a beneﬁcial thera-
peutic action for individuals in developing nations. The action of
the STpeptides could prevent proliferation at relatively early stages
of tumor growth, thus providing resistance to intestinal neoplasia
(Pitari et al., 2003).
REPRODUCTIVE FUNCTIONS
Even though GC-C is predominantly expressed in the intestinal
epithelia, extra-intestinal sites of expression have been discovered,
suggesting that signaling mediated by GC-C and its ligands may
play a role in extra-intestinal tissue as well. The mammalian testis
and ovary both display the presence of the GC-C transcript (Jaleel
et al., 2002). However its role in these tissues is unclear. One can
speculate that GC-C regulates ﬂuid–ion homeostasis in the ductal
systems of these glandular tissues.
Although the effect of NO on cGMP accumulation and smooth
muscle relaxation has been well characterized, the function of
cGMP produced by receptor GCs is poorly understood. Cyclic
GMP accumulation in the pregnant myometrium is able to
relax oxytocin-induced contractions. This response was elicited
in response to uroguanylin and was not dependent on the NO-
sensitive soluble guanylyl cyclases, pointing toward a possible
compartmentalization of the cGMP signal. Indeed, uroguanylin
and GC-C are co-expressed in the uterus, and GC-C is enriched in
the lipid raft fraction of myocytes (Buxton et al., 2010). Therefore,
it is possible that smooth muscle relaxation in uterine tissue is
elicited by GC-C and its ligands. Similarly, uroguanylin has been
shown to elevate cGMP levels in human corpora cavernosa, result-
ing in its relaxation, leading to the possibility of targeting receptor
guanylyl cyclases for the treatment of erectile dysfunction (Sousa
et al., 2010).
The rat epididymis revealed the presence of differentially gly-
cosylated forms of GC-C, and epididymal minces responded to
uroguanylin by elevation of cGMP levels (Jaleel et al., 2002). The
function of this signaling pathway in the epididymis is open to
speculation, since the reproductive capacity of GC-C knock-out
animals is not altered.
CONCLUSION
We have attempted to highlight here recent ﬁndings on the diverse
roles of guanylin and uroguanylin in vertebrate physiology. These
peptides, as well as their receptor, GC-C, are evolutionarily con-
served. Orthologs are found in ﬁshes, amphibians, reptiles, and
birds, indicating the need for this cGMP-signaling machinery in
higher eukaryotes (Krause et al., 1997; Yuge et al., 2003). While
early research focused on the importance of the ligands and the
receptor in intestinal physiology, it is clear that their roles are
varied and distinct in different tissues. We anticipate a greater
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awareness of the non-classical roles that GC-C and its ligands
may play in vertebrate physiology in coming years, and suggest
that some effects mediated by them may turn out to be cGMP-
independent. For example, novel receptors for these peptides may
be identiﬁed that are not coupled to a guanylyl cyclase, and the
complex domain organization of GC-C may allow the formation
of intracellular signaling complexes that elicit responses inde-
pendent of the guanylyl cyclase domain. Exciting times indeed
lie ahead.
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